ACCENT: AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer
Clinical trial NCT05355298 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05355298
- Sponsor
- Amplia Therapeutics Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-31
- Primary completion
- 2027-02-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.